SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: TATRADER who wrote (1124)6/20/1998 8:06:00 PM
From: Double E  Read Replies (1) | Respond to of 4140
 
TO ALL:

This was posted on Yahoo by someone at the Red Chip Conference. Pretty good reading!

A BIG PLUS
godfearinginvestor
Jun 20 1998
6:22PM EDT

Yesterday I attended the Red Chip conference with my brother and my friend and we were all impressed as to the bright future that is in store for SNRS. Here's why.

A: The clinical trials are in the third and final phase of testing
and there has not been even one person who has been injured
during this non-invasive procedure. The FDA will permit a small
number of failures during a trial, but SNRS doesn't even have a
single person who has been hurt or who has had their vision
damaged in any way by this promising technology.

B: SNRS has hundreds and hundreds of doctors who wish
to use this system when it is FDA approved. These phyiscians
are waiting on the sideline until they are given the green light.
They are ready, willing and able to become SNRS customers.
HUNDREDS AND HUNDREDS OF PENDING ORDERS MAKE STOP AND TAKE A REAL H HARD LOOK AT THIS.

C: Deborah Lowenthal, the analyst with the Red Chip
people said to me that she thought that this stock would bounce
around a little bit until the FDA third phase of the trials were
completed. After that, she thought that it would settle down in
the low teens until final FDA approval at which time it would move up to the high teens to the low twentys. After that, this stock will rocket up if there is good acceptance from the medical community.

D: A Paine-Webber Vice Pesident told me that he was very
positive as to the future of SNRS. He said that he looks carefully
at new medical devices and procedures and he thinks that this
stock "is better that VISX".

E: VISX is the #7th best growth stock year to date in the
whole country. Think about it. This is the best place to be for
future growth and SNRS investors a truely in on the ground floor.

F: This procedure will be the product of choice for millions
and millions of people in the future. As we baby boomers age,
we want to look younger and we will have the money to do it.
In five years it will become unfashionalbe to wear glasses. The
trends towards a more youthful appearance will only further fuel
this business. I was very impressed and I am thankful that I was
turned on to SNRS. And I am truely am a God fearing investor.

Things are looking great . . . patience is the key on this one.

Have a great Father's Day!

Double E